Lancora Tablets; Broken / Partial Tablets In Blister Pack

Lancora Tablet Recall Summary Lancora 5 mg tablets are being recalled across Canada because some blister packs contain broken or partial tablets, which is a product quality issue. This recall is classified as Class III, meaning the product is unlikely to cause serious health consequences. The recall affects Lancora tablets distributed throughout Canada.

Product
Lancora 5 mg tablet
Reason
Product quality concern
Classification
Class III
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2026-06-16
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/4153c4dd-262c-4ad1-a4e0-b860a6e6e7dc